|
Change in substantial holding
|
15 May 2023 at 5:25pm
|
|
Final Director's Interest Notice - D. Williams
|
26 April 2023 at 2:55pm
|
|
Resignation of Director
|
18 April 2023 at 9:40am
|
|
US Penthrox Strategy
|
11 April 2023 at 10:20am
|
|
S&P DJI Announces March 2023 Quarterly Rebalance
|
3 March 2023 at 5:25pm
|
|
Confirmation of Half Year Results Presentation Details
|
24 February 2023 at 10:40am
|
|
2023 Half Year Presentation
|
24 February 2023 at 9:20am
|
|
2023 Half Year ASX Announcement
|
24 February 2023 at 9:15am
|
|
2023 Half Year Report (including 4D)
|
24 February 2023 at 9:15am
|
|
Half Year Results Announcement Details
|
6 February 2023 at 3:40pm
|
|
Notification of cessation of securities - MVP
|
20 January 2023 at 1:20pm
|
|
Notification regarding unquoted securities - MVP
|
20 January 2023 at 1:15pm
|
|
China Clinical Trials Discontinued
|
18 January 2023 at 9:30am
|
|
Annual General Meeting - Recording available
|
28 October 2022 at 1:25pm
|
|
Results of Meeting
|
27 October 2022 at 4:55pm
|
|
Final Director's Interest Notice - M. Johnston
|
27 October 2022 at 3:40pm
|
|
Chair and CEO Presentation to Shareholders
|
27 October 2022 at 1:00pm
|
|
Chair and CEO Address to Shareholders
|
27 October 2022 at 12:35pm
|
|
2022 Annual General Meeting Clarification
|
6 October 2022 at 11:30am
|
|
Notice of Annual General Meeting/Proxy Form
|
26 September 2022 at 2:35pm
|
|
2022 Annual Report to Shareholders
|
26 September 2022 at 10:30am
|
|
Director Appointment/Resignation
|
26 September 2022 at 10:00am
|
|
Change of Director's Interest Notice
|
12 September 2022 at 9:55am
|
|
Change of Director's Interest Notice
|
7 September 2022 at 4:35pm
|
|
Notification of cessation of securities - MVP
|
7 September 2022 at 12:40pm
|
|
Change of Director's Interest Notice
|
7 September 2022 at 9:20am
|
|
Change of Director's Interest Notice
|
6 September 2022 at 6:35pm
|
|
Change of Director's Interest Notice
|
6 September 2022 at 8:45am
|
|
Change of Director's Interest Notice
|
5 September 2022 at 9:40am
|
|
Change of Director's Interest Notice
|
5 September 2022 at 9:40am
|
|
Closing Date for Nomination of Election of Directors
|
2 September 2022 at 11:00am
|
|
Security Class Reinstatement to Quotation MVPO
|
2 September 2022 at 8:55am
|
|
Table of Top 20 Option Holders and Spread of Option Holders
|
1 September 2022 at 2:20pm
|
|
Application for Quotation of Securities
|
1 September 2022 at 12:20pm
|
|
Application for Quotation of Securities
|
31 August 2022 at 12:05pm
|
|
Completion of Retail Entitlement Offer
|
30 August 2022 at 9:55am
|
|
FY222 Full Year Results Investor Presentation
|
26 August 2022 at 9:55am
|
|
MVP Announces FY22 Full Year Results
|
26 August 2022 at 9:55am
|
|
FY22 Full Year Accounts
|
26 August 2022 at 9:50am
|
|
Security Class Suspension from Quotation MVPO
|
26 August 2022 at 9:10am
|
|
FY22 Appendix 4G
|
26 August 2022 at 9:10am
|
|
FY22 Corporate Governance Statement
|
26 August 2022 at 9:10am
|
|
Supplementary Prospectus
|
25 August 2022 at 12:45pm
|
|
Advance Notice MVP FY22 Full Year Results Release
|
23 August 2022 at 12:50pm
|
|
Change in substantial holding
|
17 August 2022 at 2:30pm
|
|
Becoming a substantial holder
|
15 August 2022 at 3:45pm
|
|
Appendix 2A Application for quotation of securities
|
12 August 2022 at 11:25am
|
|
Dispatch of Prospectus
|
11 August 2022 at 5:25pm
|
|
Entitlement Offer Notification to Ineligible Shareholders
|
11 August 2022 at 3:45pm
|
|
Completion of Placement and Institutional Entitlement Offer
|
8 August 2022 at 9:30am
|
Medical Developments International